Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals European Commission final decision, 22/08/2025, 19/09/2025

Submitted by Anonymous (not verified) on 19 September 2025 - 7:00

Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals European Commission final decision, 22/08/2025, 19/09/2025

Human medicines European public assessment report (EPAR): Zonegran, zonisamide, Date of authorisation: 10/03/2005, Revision: 37, Status: Authorised

Submitted by Anonymous (not verified) on 18 September 2025 - 16:02

Human medicines European public assessment report (EPAR): Zonegran, zonisamide, Date of authorisation: 10/03/2005, Revision: 37, Status: Authorised

ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 09:30 (CET) to 20 February 2025, 14:00 (CET)

Submitted by Anonymous (not verified) on 18 September 2025 - 11:34

ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 09:30 (CET) to 20 February 2025, 14:00 (CET)

Q&A clinic on Substance, Organisation, Referentials Management Services, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 8 September 2025, 11:00 (CEST) to 8 September 2025, 12:00 (CEST)

Submitted by Anonymous (not verified) on 18 September 2025 - 11:23

Q&A clinic on Substance, Organisation, Referentials Management Services, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 8 September 2025, 11:00 (CEST) to 8 September 2025, 12:00 (CEST)

Cancer Medicines Forum: June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 June 2025, 14:00 (CEST) to 17 June 2025, 17:00 (CEST)

Submitted by Anonymous (not verified) on 18 September 2025 - 11:18

Cancer Medicines Forum: June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 June 2025, 14:00 (CEST) to 17 June 2025, 17:00 (CEST)

Letter of intent for the submission of a worksharing procedure to the European Medicines Agency according to Article 65 of Regulation (EU) 2019/6

Submitted by Anonymous (not verified) on 17 September 2025 - 16:02

Letter of intent for the submission of a worksharing procedure to the European Medicines Agency according to Article 65 of Regulation (EU) 2019/6

Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 17 September 2025 - 15:22

Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 8, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness